# A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects

> **NCT03796013** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 28 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Entrectinib Form A
- **DRUG:** Entrectinib Form C

## Key facts

- **NCT ID:** NCT03796013
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-10
- **Primary completion:** 2019-02-06
- **Final completion:** 2019-02-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03796013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03796013, "A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03796013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*